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ABSTRACT 
 
Synthesis of Structured Phospholipids with Conjugated Linolenic Acid, and 
Evaluation of Their Physical Properties. (August 2007) 
Nathalie Quezada Arboleda, B.S., Universidad Central del Ecuador; 
M.S., Pontificia Universidad Católica de Chile 
Co-Chairs of Advisory Committee:  Dr. Ernesto Hernandez 
 Dr. Lloyd Rooney 
 
 
Structured phospholipids with conjugated linolenic acid were produced for 
potential applications in nutraceuticals and functional foods. Structured phospholipids 
were synthesized with conjugated linolenic acid (CLnA) from natural sources by 
catalytic enzymatic reaction. Pomegranate seed oil, as a natural source of CLnA, and an 
isomerized-concentrated mixture (ICM) of CLnA from flaxseed oil were used for the 
enzymatic reaction with phosphotidylcholine (PC) using Liposyme TL IM for fatty acid 
modification at 57 °C for 96 h. The enzymatic process was an effective way to produce 
structured phospholipids with CLnA. The maximum incorporation of CLnA from 
pomegranate seed oil and ICM from flaxseed oil into PC was 11.3% and 4.9% after 72 h, 
respectively. Structured lysophospholipids were also obtained as a result of the 
enzymatic reaction. The maximum incorporation of CLnA from pomegranate oil and 
ICM from flaxseed oil into lysophospholipids was 17.2% and 13.5% after 72h, 
respectively. 
Physical properties such as dropping point and viscosity at 40 and 50 °C of the 
structured phospholipids produced were measured when they were added to a chocolate 
mixture (unsweetened chocolate 94.6%, coconut oil 5% and 0.4 % phospholipids). Two 
controls were used for comparison: the chocolate mixture without phospholipids and the 
chocolate mixture with Lipoid S100 (phosphatidylcholine 94%). Structured 
phospholipids with CLnA showed lower dropping point and viscosities than the controls.  
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Oil-in-water emulsions were prepared with whey protein (1%), soy bean oil 
(10%) and phospholipids (0.5%) in a high pressure homogenizer at 20MPa. The 
emulsion stability of the emulsions prepared, control (without phospholipids), Lipoid S 
100 and structured phospholipids with CLnA were determined by visual observation of 
phase separation. The structured phospholipids emulsion showed higher emulsion 
stability than the controls. This emulsion was stable up to 108 h while the emulsion 
without phospholipid and Lipoid S100 were 48 h and 96 h stable, respectively.  
 Oxidative stability of the emulsions prepared was determined by measuring the 
peroxide value and p-anisidine value after 1, 3 and 7 days at 50 °C. Oil was extracted 
from the emulsions using isooctane:isopropanol (3:2 v/v). The structured phospholipid 
emulsions showed lower oxidative stability than the controls.  
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CHAPTER I 
INTRODUCTION 
 
Lifestyle-related diseases, such as obesity, hyperlipidemia, arteriosclerosis, 
diabetes mellitus, cancer and hypertension are increasing in industrialized countries 
(Nagao and Yanagita 2005). It has been reported that one-third of human cancers is 
associated with dietary habits and life style (Doll 1992). Modulation of dietary fat 
quality such as the balance omega-6/omega-3 has been related to immunologic functions 
diseases (Harbige 2003) and with the presence and development of insuline resistance 
and the metabolic syndrome. Quality of dietary lipids could decrease the mortality of the 
life-style diseases (Vessby 2003). 
Polyunsaturated fatty acids such as docosahexaenoic acid (DHA, 22:6, n-3), 
eicosapentaenoic acid (EPA, 20:5, n-3),  α-linolenic acid (LnA, 18:3, n-3), linoleic acid 
(18:2, n-6),  and arachidonic acid (ARA, 20:4, n-6) are vital for maintaining biofunctions 
in mammalians and may be responsible for alleviating certain human health disorders 
related to heart, circulation problems and inflammation (Kris-Etherton and others 2004). 
On the other hand, special attention has been given to conjugated fatty acids because 
they have shown beneficial biologic effects of attenuation lifestyle-related diseases (Ha 
and others 1989; Ip and others 1991; Cook and others 1993; Lee and others 1994; Park 
and others 1997).  
“Conjugated fatty acids” is a collective term for the positional and geometric 
isomers of polyunsaturated fatty acids containing conjugated double bonds. Conjugated 
fatty acids can be obtained after alkali isomerization of linoleic, linolenic and 
arachidonic acid (Nichols and others 1950). However, they can be also found in natural 
sources such beef tallow and milk fat (Ha and others 1987) in which conjugated linoleic 
acid (CLA, 18:2) is present in aprox. 1%. Other sources of these fatty acids are some  
______________ 
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seed oils which contain conjugated linolenic acid (CLnA, 18:3) in levels between 30- 
70% such as pomegranate seed oil (72%; 9cis, 11trans, 13cis) bitter gourd seed oil (60-
70%; 9cis, 11trans, 13trans), tung seed oil (60-70%; 9cis, 11trans, 13cis), catalpa seed 
oil (31%; 9trans, 11trans, 13cis), and pot marigold seed oil (33%; 8trans, 10trans, 12cis) 
(Nagao and Yanagita 2005).  
Conjugated linolenic acids have shown interesting biological effects such as: 
anticarcinogenic (Igarashi and Miyazawa 2000; Hora and others 2003; Albrecht and 
others 2004; Kohno and others 2004; Mehta and Lansky 2004; Tsuzuki and others 
2004b), improving immune function and lipid metabolism (Yamasaki and others 2006), 
prevention and treatment of inflammation (Lansky and Newman 2007), decrease body 
fat content (Koba and others 2002), hypoglycemic (Akhtar and others 1981; Chao and 
others 2003; Chuang and others 2006), hypolipidemic (Jayasooriya and others 2000; 
Noguchi and others 2001; Koba and others 2002) and antioxidant (Dhar and others 1999; 
Dhar and others 2006).    
Other lipids of great interest are phospholipids. Phospholipids have shown 
important biological functions and health benefits, and are currently used at several food 
products (Schneider 2001). These compounds play an important role in biological 
functions such as maintaining cell membranes integrity, prevention of neurological 
diseases and regulation of basic biological processes such as cell to cell signaling (Guo 
and others 2005). Phospholipids have shown health benefits such as reducing blood 
cholesterol and triglycerides (Knuiman and others 1989), liver detoxification and repair 
of damaged liver tissue (Lieber and others 1990), improvement of cognitive functions 
(Pepeu and others 1996), and visual acuity (Koletzko and others 1995). Besides, 
phospholipids display amphipathic character, as components of bilayers or micelles and 
liposomes and have been applied in food, cosmetic and pharmaceutical products. 
Phospholipids have been used as natural emulsifiers, wetting and dispersing agents 
(Szuhaj 1983) and as liposome formers. These unique characteristics have made 
phospholipids the target of product development where specific structures are able to 
meet particular nutritional and, pharmaceutical requirements (Guo and others 2005). 
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Moreover, phospholipids may be considered an effective and versatile delivery system 
of functional compounds because they may increase their bioavailability and 
chemopreventive effect (Hossen and Hernandez 2005).   
Structured phospholipids are phospholipids in which the head group and/or fatty 
acid composition have been changed. Structured phospholipids have been synthesized 
with diverse fatty acids such as oleic acid (Yagi and others 1990), heptadecanoic acid 
(Svensson and others 1992), caprylic acid and eicosapentaenoic acid (Peng and others 
2002), docosahexaenoic acid (Peng and others 2002; Hosokawa and others 1998) 
conjugated linoleic acid (Hossen and Hernandez 2005; Peng and others 2002) and 
phytosterols (Hossen and Hernandez 2004). Structured phospholipids with conjugated 
linolenic acid (CLnA) may be desirable for the development of “nutraceutical lipids” 
which may improve health, and prevent or treat disease (Hossen and Hernandez 2005).  
This research is focused on the synthesis of structured phospholipids with CLnA 
from pomegranate seed oil and flaxseed oil. 
Specific objectives were: 
1. Isomerization of fatty acids of flaxseed oil to obtain conjugated linolenic acids. 
2. Synthesis of structured phospholipids with CLnA from flaxseed oil. 
3. Synthesis of structured phospholipids with CLnA from pomegranate seed oil.  
4. Examine four physicochemical properties of the structured phospholipids produced 
from pomegranate seed oil: dropping point, viscosity, emulsion stability, and oxidative 
stability. 
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CHAPTER II 
LITERATURE REVIEW: SYNTHESIS OF STRUCTURED 
PHOSPHOLIPIDS WITH CONJUGATED LINOLENIC ACID (CLnA) 
2.1. Phospholipids 
 
There is a great diversity of phospholipids in nature. The most known 
phospholipid is lecithin which is a mixture of several phospholipids present in cells and 
plant membranes. Common sources of lecithin are soybean oil or egg yolk. Lecithin is 
usually defined as a mixture of acetone insoluble polar lipids and triglyceride oil 
together with other minor components produced by degumming of crude vegetable oils 
and animal fats (Szuhaj 1988). 
Phospholipids generally contain a glycerol or a sphingosyl backbone and are 
classified into main four classes: glycerophospholipids, sphingolipids, ether 
phospholipids and phosphonopholipids, depending on their backbones and bonding 
types (Akoh and Min 1998). Glycerophospholipids are built up from glycerol, fatty 
acids, phosphoric acid, and a second hydroxyl compound which commonly contains 
nitrogen. The hydroxyl group can be choline, ethanolamine, serine, inositol and glycerol 
(Figure 1).    
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CH2- O- C- R1
CH2 - O- C - R2
CH2 – O – P- O – X+
O
O
O
O-
X = - CH2 - CH2- N+- CH3  Choline - Phosphatidylcholine
CH3
CH3
X = - CH2 - CH2- NH3+- Ethanolamine - Phosphatidylethanolamine
X = 
OH OH
OH
OHOH
Inositol - Phosphatidylinositol
R1, R2 = alkyl groups of fatty acids
Figure 1. Structure of glycerophospholipids 
 
2.1.1. Functional properties of phospholipids and application in foods 
 
Phospholipids have multiple applications due to their surface-active properties. 
Phospholipids have a bipolar, amphiphilic molecular structure due to a lipophilic part in 
the form of two fatty acids and a hydrophilic group in the form of a phosphoric acid 
ester. Because of this amphipathic character, phospholipids tend to form bilayer 
structures or micelles which make them possible to encapsulate specific reactive agents 
into so called liposomes (Figure 2) (Bretscher 1985, van Nieuwenhuyzen and Szuhaj 
1998).  
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Hydrophilic Head
Hydrophobic Tail
Bilayer
structures
Micelle
Phospholipid
 
Figure 2. Functional properties of phospholipids 
 
Phospholipids have been used in a range of food products as emulsifiers, 
stabilizers, control crystallization agents, viscosity modifiers, antioxidants and reducers 
or replacers of fat (Silva 1990; Sinram 1991). Table 1 shows some food applications of 
phospholipids. 
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Table 1. Functional properties of phospholipids 
 
APPLICATION FUNCTIONALITY 
Baked goods Volume improvement 
 Dough conditioner 
 Fat dispersion 
 Anti-staling 
 Egg Yolk replacer 
Chocolate Viscosity modification 
 Water uptake Ice coatings 
Instant drinks Wetting 
Dairy Dispersability 
Cocoa/Chocolate Dispersabilty 
 Fat reducer 
 Reduce viscosity 
 Inhibit bloom 
Margarine Anti-spattering 
 Emulsification 
 Improve spreadability 
Baking-pan release products Antisticking 
Flavours Encapsulation 
Release agents Separation 
 Wetting 
Confectionary Antisticking  
Vegetable Oils Antioxidant  
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2.1.2. Biological properties and health benefits of phospholipids 
 
Phospholipids along with proteins are the major structural components of 
membranes of all kinds of cells, from bacteria (with few exceptions) to mammalian 
tissues. The key of phospholipids biological role is the ability of the phosphate group to 
combine with water and hydrophilic molecules such as proteins, sugars, oxygen while 
the fatty acids will combine with hydrophobic substances such as hormones and non-
esterified fatty acids (Bretscher 1985). 
Phospholipids are vital in some essential biological functions in live organisms. 
They are important in maintaining cell membranes integrity and play a significant role in 
functions such as: membrane permeability, membrane fluidity, membrane interactions 
(lipid-protein) and membrane deterioration (Bezrukov 2000; White and others 2001). 
Phospholipids are involved in metabolism-related and neurological diseases (Lohmeyer 
and Bittmann, 1994; Lee 1998) and in the regulation of basic biological processes as 
signaling compounds (Izumi and Shimizu 1995; Hannun and others 2001). Furthermore, 
phospholipids act as emulsifiers in the bile digestive fluid, ensuring fine dispersion of 
fatty food molecules in the water phase, thus improving digestion and absorption (Kidd 
2002). Phospholipids combined with bioactive substances can enhance their 
bioavailability such as in the case long-chain polyunsaturated fatty acids (Carnielli and 
others 1998), n-3 polyunsaturated fatty acids (Cansell and others 2003, Cansell and 
others 2006) and tocopherol (Nacka and others 2001). Phospholipids act also as surface-
active wetting agents in the lungs (Robertson and others 1990), intestines and kidneys, 
phospholipids ensure miscibility at air-liquid and liquid-solid interfaces (Kidd 2002). 
Phospholipids have been used as nutritional supplements because they have 
shown beneficial physiological effects. Soy phospholipids mixtures have shown to 
reduce elevated blood cholesterol and triglycerides (Wilson and others 1998), soy 
phosphatidyl choline helps in liver detoxification and repair of damaged liver tissue 
(Lieber and others 1990) and phosphatidyl serine from soybean, brain and other sources 
improves cognitive functions (Pepeu and others 1996). Egg phospholipids have been 
used in infant formula to improve visual acuity (Koletzko and others 1995).  
  
9 
2.2 Modification of lipids 
 
Functional, physical and quality properties of lipids are directly related with the 
fatty acid composition and position in the triacylglycerol molecule and, the nature of the 
fatty acid constituents such as degree of unsaturation, chain length and geometric 
isomers. Lipids either in the form of triacylglycerols or as phospholipids have been 
subject of study for their modification to attain specific physical, functional or nutritional 
characteristics. 
2.2.1 Structured lipids 
 
Structured lipids are tailor-made fats and oils with improved nutritional or 
physical properties through the incorporation of new fatty acids or the change of the 
position of existing fatty acids on the glycerol backbone (Akoh 1995). Structured lipids 
may be developed with specific fatty acids that offer health or functional benefits for the 
structured lipid. Besides, the specific fatty acid and its position in the triacylglyceride 
molecule determine the functional and physical properties, the metabolic fate, and the 
health benefits of a structured lipid (Akoh and Min 1998). Structured lipids have been 
developed for nutrition and medical applications such as infant formulas, low calorie 
fats, enteral and parenteral nutrition as well as food applications with specific 
functionalities such as plastic fats, cocoa butter alternatives, frying oils, etc, (Osborn and 
Akoh 2002). 
A great variety of fatty acids have been used in the synthesis of structured lipids 
taking advantage of the functions and properties of each to maximize the benefits of a 
given structured lipid. Short and medium chain fatty acids have been used for the 
production of structured lipids due to the advantages associated with their digestability, 
absorption, and metabolism (Fomuso and Akon 1997; Mu and Hoy 2000; Fomuso 
2002). Structured lipids have been synthesized with long polyunsaturated fatty acids 
such as conjugated linoleic acid (Lee and others 2004; Lumor and Akoh 2005; 
Villeneuve and others 2007; Guo and Sun 2007), conjugated linolenic acid (Lumor and 
Akoh 2005), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
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(Halldorsson and others 2001; Hamam and Shahidi 2005; Hamam and Shahidi 2006) to 
take advantage of the health benefits associated with these compounds. 
Two main processes have been used for the production of structured lipids: 
chemical interesterification and enzymatic synthesis. Chemical synthesis involves 
hydrolysis of a mixture of medium chain triacylglycerides and long chain 
triacylglycerides and then re-esterification after random mixing of the medium chain 
fatty acids and long chain fatty acids (transesterification). The reaction is catalyzed by 
alkali metals or alkali metal alkylates (Akoh 1995). This process requires high 
temperature and anhydrous conditions. This process is inexpensive and easy to scale up 
but the reaction lacks of specificity and offers little or no control over the positional 
distribution of fatty acids in the final product (Willis and others 1998). 
The enzymatic synthesis uses lipases which occur widely in nature and can 
hydrolyze triacylglycerols to diacylglycerols, monoacylglycerols, free fatty acids and 
glycerol. Lipases can catalyze the hydrolysis of triacylglycerols and the 
transesterification of triacylglycerols with fatty acids (acidolysis), direct esterification of 
free fatty acids with glycerol and reaction of a triacylglycerol with an alcohol 
(alcoholysis) (Akoh and Min 1998). Lipase-catalyzed reactions are a combination of 
esterification and hydrolysis reactions. A continuously removal of water is important 
during the reaction in order to increase the esterification reactions, minimizing 
hydrolysis and obtaining high yield products. However, some water is necessary in the 
system to maintain enzyme dynamics during noncovalent interactions. Thus, a balance 
between hydrolysis and esterification is necessary. Lipases offer a great advantage in 
catalyzed interesterification reactions because they can control the positional distribution 
of fatty acids in the final product, due to their selectivity and regiospecificity (Akon and 
Min 1998; Haman and Shahidi  2005).  
The production of structured lipids can be carried out in organic solvents, where 
substrates are soluble, hydrolysis can be minimized and they are less likely to cause 
enzyme inactivation in esterification reactions. However, the type of solvent for the 
reaction should be considered carefully as it can dramatically affect the reaction kinetics 
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and catalytic efficiency as well as the stability of the enzyme. Hydrophilic or polar 
solvents can penetrate into the hydrophilic core of the proteins and alter their functional 
structure (Senanayake and Shahidi 1999). 
Optimum temperatures for active lipases are 30 to 40 ºC (Shahani 1975). When 
the temperature increases, enzyme molecules unfold by destruction of the disulfide 
bonds, hydrolysis of peptide bonds and deamidation of aspargine and glutamine 
residues. These processes can be avoided in a water-free environment or by 
immobilization of the enzyme which result in great thermostability.  
Other factors that affect enzymatic activity and product yield include pH, 
substrate molar ratio, enzyme activity and load, incubation time, specificity of enzyme to 
substrate type and chain length, and regiospecificity (Akoh and Min 1998). The 
advantages of the enzymatic reactions over the chemical reactions are energy saving and 
minimization of thermal degradation. 
Genetic techniques have also been used to modify the composition of oils and 
fats in order to improve their stability and quality such as to increase short chain fatty 
acid content, low linoleic, low erucic acid and high oleic acid (Broun and others 1999). 
The presence of trans fatty acids in the diet has recently become a major health concern 
for consumers because of the negative effects of trans fat in high density lipoprotein 
(HDL). Thus, several companies are actively pursing the development of seeds oils that 
contain levels of saturated fatty acids high enough to permit the elimination of the need 
for hydrogenation, and, subsequently, the production of trans fats (Knauf and Del 
Vecchio 1998).  
2.2.2 Structured phospholipids 
 
Little phospholipid variety exists in native lecithins. However, phospholipids can 
be also modified as well as lipids to improve their properties or meet particular 
functional requirements. For this purpose, the fatty acids or head group of phospholipid 
structure can be changed or modified. These modifications can be performed by 
physical, chemical, and enzymatic modification (Doig and Dick 2003). Physical 
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processes such as solvent fractionation using acetone and alcohol and chromatography 
have been used to obtain deoiled and high purity phospholipids and individual from 
commercial sources by (Doig and Dicks 2003). The chemical modification of 
phospholipids usually allows little or no control over the positional distribution of fatty 
acids in the final product (Willis and others 1998) and require high temperatures, 
solvents and anhydrous conditions making this process difficult to use in food or 
nutritional applications (Osborn and Akon 2002). Enzymatic modification offers a great 
advantage in catalyzed interesterification reactions because they can control the 
positional distribution of fatty acids in the final product, due to their selectivity and 
regiospecificity (Akoh and Min 1998). Guo and others 2005 published a review of 
enzymatic modification of phospholipids for functional applications and human 
nutrition. Figure 3 shows the enzymes most used for phospholipid modification. 
Phospholipases and lipase1- specific selectively recognize each of the four individual 
ester bonds in a phospholipids molecule (Servi 1999).  
 
CH2 O      C       R1
R2 C        O       CH2
CH2 O       P      O      X+
O
O
Phospholipase A2
Phospholipase A1, lipase
O
Phospholipase C Phospholipase D
 
Figure 3. Phospholipases and lipase in phospholipid transformation 
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Table 2 summarizes the main factors that affect enzymatic modification of 
phospholipids (Guo and others 2005).  
 
Table 2. Factors affecting the enzymatic modification of phospholipids 
Factors Remarks 
Enzyme • Phospholipase A1 and A2 or lipases can be used. 
 
• Increasing enzyme dosage may result in higher incorporation. 
 
• Increasing of enzyme may result in increased hydrolysis. 
 
• Enzyme can have different effect on phospholipids with different 
Head groups. 
Water • For some enzymes, low water activity is recommended for high 
yields. 
 • Reaction time to reach equilibrium increases with decreasing 
water activity.  
 • Water activity influences the molecular organization of 
phospholipids substrate. The packing density of phospholipids 
molecules increases with decreasing water activity. 
Acyl donor • By using a large excess of free fatty acids, hydrolysis reaction is 
Inhibited 
 
• Very high concentration of acyl donors slight decrease of in 
reaction rate. 
 
• Generally free fatty acids are more efficient acyl donors than 
their esters. 
 
• Reactivity relates to chain length and degree of saturation. 
Solvent • Solvent reduces the viscosity of the system as a consequence the 
reaction rate is increased through mass transfer increase of 
substrates.   
 
• Reaction is solvent type dependent, the rate being inversely 
proportional to solvent polarity. 
 
• Polar solvents should be avoided as they compete with the 
enzyme on available water. 
 
• Solubility of the substrate depends on solvent type. 
Reaction time • The longer the reaction time the higher the incorporation of acyl 
donors into phospholipids can be expected.  
 
• Long reaction time however may also result in increased acyl 
migration. 
Temperature • Optimal temperature changes with enzyme source and type. 
 
• Increased temperature may result in higher acyl migration. 
 
• Higher temperature lowers viscosity of reaction medium. 
 
• Enzyme stability has reverse relationship with temperature. 
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Enzymatic fatty acid modification of phospholipids has been attained using 
lipases 1-specific and phospholipase A2 through hydrolysis and then direct 
interesterification or re-esterification in the sn-1 and sn-2 position (Aura and others 
1995). Structured phospholipids have been synthesized with diverse fatty acids such as 
caproic acid (Adlercreutz and others 2002) using a lipase from Rhizopus oryzae in a 
water activity-controlled organic medium; oleic acid (Yagi and others 1990) using a 
lipase from Rhizopus delemar with a final content of 25% of oleic acid into 
phosphatidylcholine; heptadecanoic acid (Svensson and others 1992) using Rhizopus 
arrhizus lipase with an incorporation nearly of 50% into phospholipid, caprylic acid and 
eicosapentaenoic acid were incorporated into phosphatidylcholine using Thermomyces 
lanuginosa lipase (Peng and others 2002) in a solvent free-system, docosahexaenoic acid 
using Thermomyces lanuginosa lipase (Peng and others 2002) and using porcine 
pancreatic phospholipase A2 (Hosokawa and others 1998),  and conjugated linoleic acid 
using Thermomyces lanuginosa lipase (Hossen and Hernandez 2005; Peng and others 
2002).  
The enzymatic modification of the head group has been attained by 
phospholipase D which catalyzes the transphosphatidyl reaction and hydrolysis of the 
phosphoester bond (Frohman and Morris 1999; Servi 1999). Phospholipase D has been 
obtained from plants such as cabbage and bacterial sources such as Stretomyces sp. Low 
molecular weight primary alcohols to large secondary ones have been shown to be 
substrates for phosphalipase D with different yields and selectivity (Takami and others 
1994; D’Arrigo and others 1997; Servi 1999; Iwasaki and Yamane 2004). Ulbrich-
Hoffman (2000) published a review of phospholipids used in lipid transformation and 
included a table with the head groups introduced by phospholipase D into 
glycerophospholipids. Hossen and Hernandez (2004) synthesized a phosphatidyl-sterol 
by successfully incorporating β-sitosterol into phosphatidylcholine using phospholipase 
D. 
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2. 3 Conjugated Linolenic Acid (CLnA) 
 
Conjugated Linolenic Acids (CLnAs) is a generic term for geometric and 
positional isomers of linolenic acid (C18:3) which contain conjugated double bonds. 
Figure 4 shows the structures of the conjugated fatty acid punicic acid (C18:3, 
9cis,11trans,13cis) and the non-conjugated fatty acid alpha linolenic acid (C18:3, 
9cis,12cis,15cis). 
 
CH3–CH2-CH2-CH2-CH2-CH2-CH2-CH2-CH=CH-CH=CH-CH=CH-CH2-CH2-CH2-COOH
Punicic Acid, 9cis,11trans,13cis
CH3–CH2-CH2-CH2-CH2-CH2-CH2-CH2-CH=CH-CH2-CH=CH-CH2-CH=CH-CH2-COOH
Alpha linolenic acid, 9cis,12cis,15cis
9 11 13
9 12 15
 
Figure 4. Punicic acid and alpha linolenic acid structure 
 
Due to the three double bonds of conjugated linolenic acids, they show multiple 
configurations. Table 3 shows the most important configurations of CLnAs. 
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Table 3. Most common isomers of CLnA 
Name Configuration 
Punicic Acid 9cis,11trans,13cis 
α-Eleostearic Acid 9cis,11trans,13trans 
Catalpic Acid 9trans,11trans,13cis 
Calendic Acid 8trans, 10trans, 12cis 
 
2.3.1 Sources of CLnA 
 
Conjugated linolenic acids are present in some plant seed oils. Table 4 shows the 
principal sources of CLnAs, content and principal isomer.  
 
Table 4. Natural sources of CLnAs 
Source Content 
(%) 
CLnA Isomer 
Pomegranate (Punica granatum) seed oil 
 
72 Punicic acid 
 
Bitter gourd (Momordica Charantia L.) oil 60 α-Eleostearic acid 
 
Tung seed (Aleurites moluccana) oil 70 α-Eleostearic acid 
Catalpa (Catalpa ovata) seed oil 31 Catalpic acid 
 
Pot marigold (Calendula officinalis) seed oil 33 Calendic Acid 
 
 
Pomegranate (Punica granatum) has been of special attention of scientists in the 
last 7 years because each part of the plant (seeds, juice, peel, leaf, flower, bark and root) 
has shown interesting pharmacologic activities (Lansky and Newman 2007). This fact is 
reflected by the number of scientific publications about the bioactivities of this plant 
presented in the last 7 years (7 times) compared with the number of publications 
presented between 1950 -1999. Lansky and Newman (2007) published a review in 
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pomegranate and its potential for prevention and treatment of inflammation and cancer. 
There is a lot of scientific interest in pomegranate seed oil because this oil has shown 
anticancer properties (Toi 2003; Mehta and Lansky 2004; Hora 2003; 2004; Kohno 
2004).  
CLnAs can be synthetically produced by alkali isomerization which has been 
used for the commercial production of conjugated linoleic acid (CLA). Natural sources 
with a high content of linolenic acid such as flaxseed oil may be used for this purpose.  
2.3.2 Metabolism of CLnAs 
 
Studies of the metabolism of α-eleostearic acid and punicic acid in rats have 
demonstrated that these acids are metabolized to conjugated linoleic acid (CLA) by 
enzymatic hydrogenation. Tsuzuki and others (2004a) determined that α-eleostearic acid 
is converted to conjugated linoleic acid (CLA; 9cis,11trans–18:2) in the liver and plasma 
of rats when these animals were fed with diets including 1% α-eleostearic acid for 4 
weeks. The concentrations of conjugated linolenic acid and CLA were determined after 
0, 3, 6, and 24 h oral administration of α-eleostearic acid to rats. Furthermore, these 
authors determined also that enteric bacteria are not involved in the conversion of α-
eleostearic acid to CLA using germ-free rats but they demonstrated that the conversion 
of α-eleostearic acid into CLA was enzyme-mediated. α-Eleostearic acid was reacted 
with tissue homogenates (liver, kidney, and small intestine mucous) and coenzymes 
(NADH, NAD+, NADPH, and NADP+), and the enzyme activities were estimated from 
the amount of CLA produced. CLA was detected when α-eleostearic acid was reacted 
with liver, kidney, and small intestine mucous homogenates and coenzyme NADPH. 
These results indicated that α-eleostearic acid is converted to 9cis, 11trans-CLA in rats 
by a ∆13-saturation reaction carried out by an NADPH-dependent enzymatic reaction 
that occurred rapidly in rat liver and small intestine. In a later article, these authors 
(Tsuzuki and others 2006) studied the characteristics of absorption and metabolism of α-
eleostearic acid in the small intestine of rats such as the ratio of conversion of α-
eleostearic to CLA and absorption of this fatty acid and compared with the unconjugated 
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fatty acid linolenic acid (LnA) and CLA. Tsuzuki and others 2006 studied also whether 
structural differences of CLnAs affect absorption in the small intestine as well as 
whether the saturation reaction occurs regardless of the configuration (cis or trans) of the 
double bonds comparing α-eleostearic (9cis, 11trans, 13trans) with punicic acid (9cis, 
11trans, 13cis). The structure and configuration of metabolites produced after the 
digestion of both fatty acids were determined by GC-EI-MS and 13C-NMR. The results 
of this study showed that most of the LnA, CLA, α-eleostearic acid and punicic acid fed 
to the rats were absorbed within 24h. The absorption rate was LnA>CLA>α-
Eleostearic>punicic acid. α-Eleostearic as well as punicic acid were converted in CLA 
(9cis, 11trans -18:2) in the rat intestine. Approximately 21% and 12% of the α-
eleostearic and punicic acid were absorbed by the rats and converted to 9cis, 11trans-
CLA. The double bond that underwent saturation in α-eleostearic was the 13 trans while 
in punicic acid was the 13 cis double bond.  
In another study (Noguchi and others 2001), the formation of the CLA isomer in 
the liver lipids of rats fed with bitter gourd oil diets could be explained by either of the 
following two metabolic pathways, namely, enzymatic biohydrogenation of 
9cis,11trans,13trans- 18:3 or enzymatic isomerization of 9cis,12cis-18:2. 
Most of the commercial conjugated linoleic acid (CLA) is obtained by alkali 
isomerization of safflower oil. Conjugated linoleic acid (CLA) is present in foodstuffs in 
just 1% in comparison with CLnAs which can be found in natural sources at high 
concentrations (30-70%). As mentioned above, Tsuzuki and others 2004a demonstrated 
that CLnAs are slowly metabolized in the rat intestine to 9cis, 11trans-CLA. Thus, 
CLnAs may be used as a source of 9cis, 11trans-CLA after metabolism providing the 
health benefits associated with this isomer.  
2.3.3 Health benefits of CLnA 
 
Conjugated linolenic acids have shown important health benefits such as 
anticarcinogenic (Igarashi and Miyasawa, 2000; Tsuzuki and others 2004b; Yashui and 
others 2005), hypoglycemic (Akthar and others 1981; Chuang and others 2006), 
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hypolipidemic (Jayasooriya and others 2000, Noguchi and others 2001, Koba and others 
2002), reduce body fat content (Koba and others 2002), antioxidant effects (Dhar and 
others 1999; Dhar and others 2006), immuno function (Yamazaki 2006) and prevent and 
treat inflammation (Lansky and Newman 2007).  
2.3.3.1 Anticancer properties 
 
Conjugated linolenic acids have shown selective cytotoxic activity on several 
tumors cell lines (Table 5).  Some studies have suggested that citotoxic activity of these 
fatty acids involves lipid peroxidation and the alteration in fatty acid composition of 
membrane phospholipids, eicosanoid synthesis and membrane fluidity (Igarashi 2000). 
α-Eleostearic acid have shown stronger antitumor effect than CLA (conjugated linoleic 
acid) both in vivo and in vitro. The proposed mechanism for this activity of CLnAs is 
apoptosis (cell death) induction via lipoperoxidation (Tsuzuki 2004b). 
Pomegranate seed oil rich in punicic acid has demonstrated to have anti-
angiogenic activity (Toi and others 2003). Angiogenesis is the physiological process 
involving the growth of new blood vessels from pre-existing vessels. Angiogenesis is a 
critical process for the development and progression of cancer. The anti-angiogenic 
effect was evaluated by measuring the vascular endothelial growth factor (VEGF), 
interleukin-4 (IL-4) and migration inhibitory factor (MIF) in the conditioned media of 
estrogen sensitive (MCF-7) or estrogen resistant (MDA-MB-231) human breast cancer 
cells or immortalized normal human breast epithelial cells (MCF-10A) grown in the 
presence or absence of pomegranate seed oil or fermented juice polyphenols.      
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Table 5. Anticancer properties of CLnAs 
Oil/Acid Compound Cells Type Reference 
Pomegranate seed oil Punicic acid Breast   Toi 2003; Mehta and 
Lansky, 2004 
  
Skin  Hora 2003 
  
Prostate Mehta and Lansky, 
2004  
  
Colon Kohno 2004 
Isomerized of linolenic 
acid, α-linolenic acid and 
tung oil 
 
Colorectal, 
hepatoma, lung, 
breast, stomach  
Igarashi and 
Miyasawa, 2000  
Bitter gourd oil Α-
Eleostearic 
acid 
Colon Igarashi and 
Miyasawa, 2000, 
Yasui et al. (2005) 
 
2.3.3.2 Hypoglycemic effects 
 
Bitter gourd is a common vegetable used in Asia and has been use in traditional 
medicine for the treatment of Diabetes. The hypoglycemic effect of α-eleostearic was 
demonstrated by Akhtar and others (1981). The peroxisome proliferator activated 
receptors (PPARs: PPARα, PPARγ, PPARδ) are ligand-dependent transcription factors 
that belong to the steroid hormone nuclear receptor family and control lipid and glucose 
homeostasis in the body (Desvergne and Wahli 1999). Chao and Huang (2003) 
demonstrated that an ethyl acetate extract from bitter gourd activated not only PPARα 
but also PPARγ and regulated the expression of PPARγ target genes in H4IIEC3 cells. 
Later these authors found that 9cis, 11trans, 13trans-conjugated linolenic acid was 
responsible for the effect on PPARs (Chuang and others 2006). 
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2.3.3.3 Hypolipidemic effects 
 
Noguchi and others (2001) studied the effects of bitter gourd oil (BGO) on blood 
and liver lipids of rats. In this study, three groups of rats were given a basal diet 
containing 7% fat by weight. The dietary fat consisted of soybean oil (control), soybean 
oil + BGO (6.5:0.5, w/w; 0.5% BGO), or soybean oil + BGO (5:2, w/w; 2.0% BGO). 
This fat treatment gave 3.4 and 15.4% of 9cis, 11trans, 13trans -18:3 in the dietary fat of 
0.5 and 2.0% BGO, respectively. Fatty acid analysis showed the occurrence of 
9cis,11trans-18:2 in the liver of rats fed BGO diets, whereas this conjugated linoleic acid 
(CLA) isomer was not detected in the liver of rats fed the control diet. Furthermore, 
dietary BGO decreased the concentration of 18:2n-6 and increased the concentration of 
22:6n-3. The BGO diets significantly reduced free cholesterol levels with a trend toward 
an increase in HDL cholesterol, but there was no significant change in the total 
cholesterol. The dietary BGO also affected the plasma level of hydroperoxides, a slight 
but significant increase in hydroperoxides. 
Arao and others (2004) studied the effect of 9cis, 11trans, 13cis conjugated 
linolenic acid on Apolipoprotein B100 secretion and triacylglycerol synthesis in HepG2 
cells. ApoB100 is an essential component in very low density lipoprotein and its blood 
level is positively correlated with the incidence of coronary heart disease and 
atherosclerosis. 9cis, 11trans, 13cis Conjugated linolenic acid significantly decreased 
apolipoprotein B100 secretion compared with α-linolenic acid. The uptake of 14C-oleate 
into newly synthesized cellular triacylglycerol decreased more when 9cis, 11trans, 13cis 
conjugated linolenic acid was supplied in the diet than when α-linolenic acid was 
provided. 
2.3.3.4 Reducing body fat content 
 
Koba and others (2002) studied how dietary CLnAs affected body fat mass as 
well as serum and liver lipids in rats and compared with those of CLA, LnA and LA. 
Feeding CLnAs reduced the weight of perirenal adipose tissue significantly more than 
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LA and LnA. The body fat-reducing effect of CLnAs was comparable or even stronger 
than that of CLA under the experimental conditions of this study. On the other hand, 
serum triacylglycerides (TG) was 2.5 fold higher in rats fed with CLnAs than those fed 
with LA, LnA and CLA. It is expected from this fact that serum cholesterol should be 
higher too. However, serum cholesterol concentration was significantly lower in rats fed 
with CLnAs than those with LA. The elevated level of TG may be explained by an 
inability to clear very low density lipoprotein (VLDL) possibly by inhibition of 
lipoprotein lipase activity as the rats were fasted 16 h prior to collection of blood. 
CLnAs may reduce more efficiently fat deposition than CLA, as CLA contained 33% of 
10trans, 12cis-18:2 (which has shown to inhibit lipoprotein lipase activity) and CLnAs 
just contained 15% of this isomer and 32% and 17% of conjugated 18:3. Furthermore, 
rats fed with CLnAs showed increased concentration of free fatty acids (FFA) than those 
fed with LA and LnA suggesting that CLnAs may increase fatty acid mobilization from 
adipose tissues. 
This research also investigated the effect of adipocytokines such as leptin and 
TNF-α as these compounds may modulate the amount of adipose tissue. TNF-α has 
shown to decrease the synthesis of lipoprotein lipase in adipose tissue but increase the 
activity of lipoprotein lipase in the liver. TNF-α was reported to decrease PPARγ mRNA 
level in 3T3-L1 preadipocytes. Recent studies have shown that PPARγ mRNA levels in 
adipose tissue of obese women were positively correlated with serum concentrations of 
HDL-cholesterol. In this study, serum leptin level was found to exhibit a significant 
correlation with the weigth of perirenal and epididymal adipose tissues and with serum 
HDL-cholesterol. Serum leptin and HDL cholesterol levels were the lowest in the 
CLnAs group which could explain why CLnAs (more than CLA) decreased the weight 
of adipose tissues more than the corresponding non conjugated fatty acids. Besides, in 
the liver, CLnAs significantly enhanced the activity of mitocondria and peroxisomal β-
oxidation as it was 3-3.5 fold in rats fed with CLnA as compared with the other diets. 
This may be explained by the fact that CLnA activated PPARα which regulates hepatic 
β-oxidation. The feeding of CLnA affected hepatic lipid metabolism more potently than 
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CLA and resulted in a net reduction in adipose tissue weight which may be explained by 
a decrease in TG deposition from circulation and/or lipolysis in adipose tissues.  
2.3.3.5 Antioxidant activity 
 
Degenerative diseases such as Diabetes mellitus (Type I), cardiovascular disease, 
arthritis and aging require antioxidative defense systems against the oxidative stress 
generated by them (Dhalla and others 2000; Sayre and others 2001). CLnAs have shown 
scavenging action against lipid peroxidation. Dhar and others (1999) demostrated that 
CLnAs significantly lowered plasma lipid peroxidation, erythrocyte membrane lipid 
peroxidation and liver tissue lipid peroxidation in comparison with the sunflower oil 
group at a 0.5% level. The antioxidant activity decreased as the concentration of CLnAs 
increased. 
In another study Dhar and others (2006) investigated the antioxidant effect of 
CLnAs in the absence and presence of α-tocopherol. CLnAs + α-tocopherol diet 
decreased liver lipid peroxidation significantly more than α-tocopherol alone. A possible 
explanation of the antioxidant activity of CLnAs is based on the bioconversion reactions 
of CLnAs. Under in vivo conditions, CLnAs can undergo isomerization, hydrogenation, 
and oxidation reactions to form PUFA of both nonconjugated acids (LA and LnA) and 
conjugated fatty acids. It is known that CLA posses antioxidant activity (Ip and others 
1991). This fact may explain the antioxidant activity of CLnAs even at reduced doses 
with a fixed dose of α-tocopherol. The results of this study showed also a synergestic 
antioxidant effect of CLnAs with α-tocopherol in vivo on lipid peroxidation in diabetic 
rats. 
2.3.3.6 Immune function 
 
Modulation of dietary fat quality such as the balance omega-6/omega-3 is related 
to immunologic functions (Harbige 2003). On the other hand, conjugated fatty acids 
such as conjugated linoleic acid (CLA) has shown to promote strong immune function 
through the production of immunoglobulin (Ig) and modulate the production of some 
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cytokines (signaling compounds important in immune response) in rat and mouse 
splenocytes (characteristic white blood cells of splenic tissue) (Sugano and others 1998).  
Yamasaki and others (2006) studied the dietary effect of pomegranate seed oil on 
immune function and lipid metabolism in mice. In this study, mice were fed with 
experimental diets containing 0%, 0.12% or 1.2% of pomegranate seed oil for 3 weeks. 
Splenocytes isolated from mice fed with 0.12% and 1.2% pomegranate seed oil diet 
produced larger amounts of immunoglobulins G and M. These results suggested that 
pomegranate seed oil may enhance immune response in vivo.   
2.3.3.7 Inflammation 
 
Prostaglandins are a complex group of oxygenated fatty acids that is present in 
most mammalian tissues. It has been reported that there is a positive correlation between 
prostanglandins and inflammation (Kuehl and Egan 1980). Nugteren and Christ-
Hazelhof (1987) reported the anti-inflammatory activity of naturally occurring 
conjugated trienoic acids such as jacarandic acid, calendic acid, catalpic acid, punicic 
acid and α- eleostearic acid. In this study, the anti-inflammatory activity was determined 
by measuring the 50% inhibitory concentration (IC50) (Table 6) of these fatty acids to 
cyclooxygenase, enzyme that catalyzes prostaglandin’s biosynthesis.  
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Table 6. Inhibition of cyclooxygenase by naturally conjugated linolenic acids 
Fatty acid Source Configuration [I]50 µM 
Jacarandic Jacaranda seeds  8cis,10trans,12cis (n-6) 2.4 
Calendic Pot marigold seed oil 8trans,10trans,12cis (n-6) 31 
Catalpic Catalpa seed oil 9trans,11trans,13cis (n-5) 58 
Punicic Pomegranate seed oil 9cis,11trans,13cis (n-5) 68 
α-eleostearic Bitter gourd, Tung seed oil 9cis,11trans,13trans (n-5) 200 
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CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Materials 
 
Lipoid S100 (phosphatidylcholine 94%) was donated by Lipoid GmBH 
(Ludwigshafen, Germany). Unsweetened chocolate baking bars and commercial soy 
bean oil were purchased from a local super market. Coconut oil was purchased from    
Spectrum Organic Products, Inc. (Petaluma, CA). Sweet dairy whey protein was 
purchased from Foremost Farms USA (Baraboo, WI). 
3.1.1. Chemicals 
 
Soybean phosphotidylcholine (aprox. 99%), a mixture of 37 fatty acid methyl 
esters to identify the different fatty acids, and other chemicals and reagents were 
purchased from Sigma Chemical Company (St. Louis, MO, USA). Flaxseed oil used for 
the synthesis of CLnA was supplied by a Polar Food Inc. (Manitoba, Canada). 
Pomegranate seed oil was donated by Botanic Innovations (Spooner, WI, USA). All 
solvents used were of analytical or HPLC grade and purchased from VWR-Scientific 
Products (Batavia, IL, USA). Immobilized lipase from Thermomyces lanuginose 
(Lipozyme TL IM) was supplied by Novozymes North America (Franklinton, NC, 
USA).  
3.2 Synthesis and concentration of CLnAs from flaxseed oil 
3.2.1 Synthesis of CLnA from flaxseed oil 
 
CLnA as free fatty acids were produced by alkali isomerization of flaxseed oil 
with 7% NaOH in propylene glycol at 180 °C for 2 h, according to Rocha-Uribe and 
Hernandez (2004).  Flaxseed oil (500 g) was added to a 5-liter, 3-neck flask containing 
203 g of NaOH dissolved in 2900 g of propylene glycol (7% NaOH in propylene 
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glycol). The reaction mixture was flushed with nitrogen and heated to 180 °C for 2 h. 
This mixture was cooled to room temperature, concentrated hydrochloric acid (500 ml) 
was added and it was stirred for 15 min. The pH of the reaction mixture was adjusted to 
3 with additional concentrated hydrochloric acid. The mixture was transferred to a 
separator funnel and 200 ml of water was added and extracted with 500x2 mL of hexane. 
The hexane solution was washed with 250x3 mL of deionized water, dried overnight 
with magnesium sulfate, filtered through filter paper (Watman No. 41) and placed in a 
rotary evaporator at 60 °C. The isomerized mixture was placed in a plastic bottle in a 
nitrogen atmosphere and stored at – 20 °C.  
3.2.2 Urea treatment of CLnA mixture from flaxseed oil  
 
The isomerized mixture (IM) obtained after flaxseed oil isomerization was 
treated with urea to concentrate the mixture in unsaturated fatty acids according to Yang 
and Liu (2004). CLnA mixture (5 g) was added to urea (20 g) dissolved in warm 
methanol (80 mL). The mixture was heated till complete dissolution, and then it was 
allowed to cool slowly to room temperature and stored in the refrigerator overnight at 5 
°C. The mixture was filtered under vacuum, washed with water and HCL (6 N) and 
extracted with hexane. The hexane phase was dried over anhydrous sodium sulfate and 
hexane was removed using a rotary evaporator and the remanent was stored at -20 °C. 
UV/VIS spectrophotometric analysis of the isomerized-concentrated mixture (ICM) was 
performed with a spectrophotometer Beckman DU 520 (Beckman Instrument Inc., 
Fullerton, CA, USA) at 233 nm for conjugated diene and at 262, 268 and 274 nm for 
conjugated triene fatty acids (AOAC, 1990).  
3.3. Synthesis of structured phospholipids with CLnA 
3.3.1 Lipase catalyzed acidolysis/interesterification reaction 
 
Figure 5 shows the reaction scheme for the synthesis of structured phospholipids 
with conjugated linolenic acid from pomegranate seed oil or isomerized concentrated 
mixture from flaxseed oil. Phosphatidylcholine (100 mg) was mixed with the isomerized 
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concentrated mixture (ICM) from flaxseed oil (185 mg) or pomegranate seed oil (555 
mg) in 1 mL of hexane in screw cap vial. Lipase enzyme (20 wt.% of phospholipid) was 
then added to the reaction mixture. The reaction was carried out at 57 °C in a water bath 
agitated with magnetic stirring at 250 rpm. After 24, 48, 72 and 96 h an aliquot (50 µL) 
was collected from the reaction mixture. The solvent was evaporated using N2 and 300 
µL of chloroform:methanol (2:1 vol/vol) was added to the aliquot and centrifuged for 5 
min using a mini-centrifuge (Phoenix Research System, Hayward, CA, USA). The upper 
layer was carefully withdrawn and kept in the freezer (<-20°C) for analysis. 
 
CH2-O-CO-R1
R2-OC OCH 
CH2-O-P-O-CH2CH2-N(CH3)3
O-
O
+CH2-CLnA
CLnA - CH
CH2-O-CO-R3
Pomegranate seed oil
Phosphatidylcholine
Lipase 1,3 specific
CH2- CLnA
R2-OC OCH 
CH2-O-P-O-CH2CH2-N(CH3)3
O-
O
CH2- CLnA
OHCH 
CH2-O-P-O-CH2CH2-N(CH3)3
O-
O
Structured phosphatidylcholine Structured lysophosphatidylcholine
or
CLnA
Isomerized Concentrated Mixture
From flaxseed oil
 
Figure 5. Reaction scheme of the interesterification or acidolysis enzymatic 
reaction for the production of structured phospholipids with CLnA 
3.3.2 Thin Layer Chromatography (TLC) analysis  
 
TLC is a well known analytical technique used to separate chemical products. 
The reaction products (phospholipid of the enzymatic reaction of structured 
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phospholipids with conjugated linolenic acid were separated using TLC according to 
Hossen and Hernandez (2005). The mobile phase was a mixture of 
chloroform/methanol/water (65:25:4, vol/vol/vol). The sample aliquots collected in 
chloroform:methanol (3:2 v/v) at different time intervals were applied to TLC plates 
(silica gel 60 F254; E. Merck Co., Darmstadt, Germany). Eluted compounds were 
visualized by spraying 5% phosphomolybdic acid in ethanol followed by heating.  
3.3.3 HPLC analysis 
 
The enzymatic synthesis of structured phospholipids involves interesterification 
or acidolysis reactions. However, hydrolysis or interesterification of the triacylglyceride 
or phospholipids molecule regarding the reaction conditions could occur in lipase 
catalyzed reactions (Akoh and Min 1998). The hydrolysis degree of phospholipids 
during acidolysis reaction was determined by HPLC according to Hossen and Hernandez 
(2005). The HPLC system consisted of a Beckman Gold Module (Beckman Instrument 
Inc., Fullerton, CA) with 508 auto sampler module (20 µL injection loop), 126 pump 
module and 168 UV detector module was used. A normal-phase silica column 
(Lichrosorb, Phenomenex) was used at room temperature for this analysis. The mobile 
phase was acetonitrile/methanol/phosphoric acid (130:5:1.5 vol/vol/vol) and run 
isocratically at a flow rate of 1.5 mL/min. Phospholipids were detected at 205 nm.  
3.3.4 Fatty acid analysis of structured phospholipids 
 
The percent of incorporation of conjugated linolenic acid into 
phosphatidylcholine was determined by analyzing the fatty acid composition of the 
reaction products (structured phospholipids and lysophospholipids) using preparative 
TLC followed by gas chromatography (GC) (Hossen and Hernandez 2005). Reaction 
products were first separated on preparative TLC plates (20 cm × 10 cm) using 
chloroform/methanol/water (65:25:4, vol/vol/vol) as mobile phase. The portion of the 
plate cut and revealed with 5% phosphomolybdic acid was used as a template to identify 
the phospholipid compounds which were then scraped off from the TLC plates and put 
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into a test tube for fatty acid methyl ester preparation. Fatty acid methyl esters were 
prepared by adding 1.0 mL of 0.25 M sodium methoxide in methanol to the scrapings in 
test tubes from the TLC plates. This mixture was incubated for 10 min in a water bath 
shaker at 45 °C, and 1 mL of hexane was added followed by 3 mL of saturated NaCl 
solution. Then the mixture was vortexed and centrifuged, and methyl esters extracted in 
hexane were collected from the upper layer for GC analysis. The GC system consisted of 
a Varian Model 3400 equipped with a split injector, a flame ionization detector, and a 
fused silica capillary column Supelco SP 2560 (100 m, 0.25 mm I.D., 0.20 µm film, 
Bellefonte, PA). The initial column oven temperature was 150 °C for 3 min and raised to 
200 °C at 10 °C/min, finally it was raised to 230 °C at 3 °C/min and held for 10 min. 
The injector and detector temperatures were 250 °C and 300 °C, respectively. Fatty acids 
were identified by comparing their retention times with the ones of the standards. 
3.4 Physical properties of structured phospholipids  
 
Pomegranate seed oil (31 g), Lipoid S100 (6 g) Lipozyme TL IM (1.2 g) and 30 
mL of hexane were used for the production of structured phospholipids with CLnA in 
higher scale for the study of their physical properties. The reaction mixture was placed in 
a water bath agitated with magnetic stirring at 250 rpm at 55 – 57 °C for 72 h. After this 
time, the reaction mixture was filtered and water (8 g) was added to it. This mixture was 
placed in a silicone oil bath at 50 - 55 °C with stirring for 1 h, then placed in the freezer 
for 1 h and finally centrifuged in Sorvall RC 5C Plus (Sorvall Inc., Newtown, CT) 
centrifuge at 10000 RPM for 10 min. Structured phospholipids were freeze dried in a 
Labconco Freeze Dry 5 (Labconco Corporation, Kansas City, MI) for 16 h. 
Phospholipids have been used in chocolate as a viscosity reducer and cocoa 
butter replacer (van Nieuwenhuyzen 1995; Sinram 1991). The effects of structured 
phospholipids with CLnA in the physical properties of a food product were evaluated 
through their incorporation in a chocolate system and the dropping and viscosity were 
determined. The chocolate system consisted in a mixture of unsweetened chocolate 
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(94.6%) and coconut oil (5%) and phospholipids (0.4%). Two controls were prepared for 
comparison: one without phospholipids and the other with Lipoid S100. 
3.4.1 Dropping point 
 
The dropping point is the temperature at which the sample becomes fluid enough 
to flow. Physical properties such as the dropping point (equivalent to the melting point) 
is of great significance in chocolate’s quality as this property is involved in chocolate’s 
gloss, snap and texture (Loisel and others 1998). 
The dropping point of the structured phospholipids chocolate mixture and 
controls were determined following the AOCS method Cc 18-80 using a Mettler 
processor (Mettler FP80) and a dropping furnace (Mettler FP83, Mettler Instruments 
Corp., Highstown, NJ). The sample cup was previously keep in the freezer (< °0 C) and 
then filled with approximately 15 drops of the melted chocolate mixture and placed in 
the freezer for 20 minutes. The solidified sample was placed in the furnace and warmed 
in the temperature-programmed furnace. 
3.4.2 Viscosity 
 
The viscosities of the structured phospholipids chocolate mixture and controls 
were measured in a Brookfield Rheometer HB (model DV-III, Brookfield Co., 
Stoughton, MA) using a HB2 and HB3 spindles (Brookfield Engineering Laboratories 
Inc., Stoughton, MA) at 40 and 50 °C. The temperature was controlled using a water 
bath at a constant temperature. Viscosities were reported in centipoises (cP). 
3.5 Emulsion stability 
 
Phospholipids have been used mainly as natural emusifiers. The emulsion 
stability of the structured phospholipids produced was tested through the production of 
oil-in-water emulsions which contained whey protein (1%), soy bean oil (10%) and 
phospholipids (0.5%) according to the method of Hernandez (2001). The emulsions were 
prepared in an APV Rannie Lab 2000 High Pressure Homogenizer (Albertslund, 
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Denmark) at 20 MPa. Two controls were prepared for comparison: one without 
phospholipids and the other with Lipoid S100. The emulsions prepared were placed at 
room temperature for visual observation of their stability till phase separation. 
3.6 Oxidative stability 
 
Structured phospholipids emulsion and controls were placed in a water bath at 50 
°C for 1, 3 and 7 days. After these periods, oil was extracted from the prepared 
emulsions according to Osborn and Akoh (2003). The peroxide value was evaluated 
following the AOCS official method Cd 8-53. 50 mL of acetic acid:isooctane (300:200 
v/v) were added to the oil extracted (5 g) and then 0.5 mL of saturated KI were added to 
the mixture and shaked for 1 min. After this time, water (30 mL) and starch (0.5 mL) 
was added to the mixture. This mixture was titrated with sodium thiosulfate 0.01 N till 
colorless. The p-anisidine value of the oil extracted was evaluated following the AOCS 
official method Cd 18-90. Oil extracted from the emulsion (0.4 g) was placed in a 25 mL 
volumetric flask and the volume was completed with isooctane. The absorbance of this 
solution was measured at 350 nm using isooctane as blank. 5 mL of this solution were 
placed in a glass tube and 1 ml of p-anisidine was added to the tube, and then capped and 
shaked. After 10 min the absorbance of this solution was measured. An isooctane - p-
anisidine mixture was used as blank. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
4.1 Incorporation of CLnA from Isomerized Concentrated Mixture from flaxseed 
oil into phospholipids (PC)  
 
Table 7 shows the fatty acid composition of flaxseed oil, isomerized mixture 
(IM) and isomerized concentrated mixture (ICM) from flaxseed oil after urea treatment. 
After isomerization, the concentration of CLnAs increased from 0 to 31.0% while the 
concentration of linolenic acid decreased from 50.3% to 20.3%. After the urea treatment 
the concentration of CLnAs increased from 31.0% to 43.5 %, the concentration of 
palmitic, stearic and oleic acids decreased to less than 1% while the concentration of 
linoleic and linolenic aids increased to 18.4%, 35.6% respectively. The GC analysis of 
this mixture showed one big CLnA peak and five small CLnA peaks. The big CLnA 
peak accounted for nearly 68% of the total CLnA isomers. Spectrophotometric readings 
confirmed the formation of conjugated diene and triene fatty acids. The ICM contained 
34.4% of conjugated diene and 2.5% of conjugated triene fatty acids. More research is 
required to establish the configuration of these CLnA isomers.  
The incorporation of CLnAs isomers into PC was monitored for 96 h (Fig. 6).  
After 72 h, 4.9 % CLnAs were incorporated and decreased to 4.8 % after 96 h. Fatty acid 
composition of the ICM, PC and the structured phospholipids with CLnAs are shown in 
Table 8. CLnA isomers were incorporated into PC mainly by the exchange of linoleic 
and palmitic acid. On the other hand, the percent of incorporation of oleic, linolenic acid 
and CLnAs into PC increased after 72 h. Lysophospholipids (LPC) are formed during 
the interesterification reaction (Hossen and Hernandez 2005). TLC and HPLC analysis 
of reaction products confirmed qualitative and quantitatively the formation of LPC with 
time. Percent of hydrolysis was calculated based on the relative amount of LPC present 
in the reaction products (Hossen and Hernandez 2005
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 The hydrolysis rate for the ICM from flaxseed oil (Fig. 7) was faster during the 
first 72 h reaching 44.2%, and increased slowly after this time, reaching 49.4 % after 96 
h. The hydrolysis rates of PC were higher when the ICM from flaxseed oil was used as 
CLnAs source than the pomegranate seed oil.  The pretreatments such as isomerization 
and urea concentration carried out on the flaxseed oil might favor the hydrolysis reaction 
of PC.  
 
 
 
 
 
 
 
Table 7. Fatty acid composition (%) of flaxseed oil, isomerized mixture (IM) and 
isomerized concentrated mixture (ICM) from flaxseed oil 
 
Fatty acid Flaxseed oil  IM  ICM  
C16:0 5.1± 0.62 4.8 ± 0.04 0.1 ± 0.002  
C18:0 4.1± 0.02 4.1 ±  0.15 0.2 ± 0.01 
C18:1 23.8 ± 0.23 24.7 ± 0.28  0.5 ± 0.05 
C18:2 14.2 ± 0.11 13.6 ± 0.13 18.4 ± 0.09 
C18:3 50.3 ± 0.18 20.3 ± 0.20 35.6 ± 0.14 
CLnAs ND 31.0 ± 0.75  43.5 ± 0.31 
Others 2.5 ± 0.03 1.5 ± 0.03 1.7 ± 0.01  
   †Average of two analyses. 
   ND – not detected 
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Phospholipids have been used in a range of food products as emulsifiers, 
stabilizers, control crystallization agents, viscosity modifiers, antioxidants and reducers 
or replacers of fat (Silva 1990; Sinram 1991). Table 1 shows some food applications of 
phospholipids. 
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Figure 6. % Incorporation of CLnA into phospholipids (PC) from 
isomerized concentrated mixture (ICM) from flaxseed oil and 
pomegranate seed oil (PSO) 
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Figure 7. Degree of hydrolysis of phospholipids during enzymatic reaction 
of phospholipids with isomerized concentrated mixture from flaxseed oil 
and pomegranate seed oil 
 
 
 
The fatty acid composition of lysophospholipids (LPC) showed that the 
incorporation of palmitic, stearic, oleic and linoleic was random. The concentration of 
linolenic acid and CLnAs increased after 96 h reaction time. About 13.5 % of CLnAs 
from flaxseed oil were incorporated into LPC after 72 h of reaction, which then 
decreased to 13.0 % after 96 h (Fig. 8). The higher incorporation of CLnAs into the LPC 
than the PC can be explained by the high hydrolysis rate obtained (nearly 50% after 96 
h, Fig. 6) when the ICM from flaxseed was used. The reaction has only been described 
as a transesterification reaction, but a combination hydrolysis and reesterification step 
could be possible as well. The intermediate product, 2-acyl LPC is prone to acyl 
migration, yielding the more stable 1-lyso acyl LPC (Adlercreutz and others 2002). 
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Higher incorporation rates obtained when ICM (4.9%) was used for the 
acidolysis reaction compared to IM (1.2%). This may be due to an increase in CLnAs 
concentration after the urea treatment. For production operations, further concentration 
or purification techniques of the isomers of interest prior to enzymatic synthesis may be 
required for increased incorporation levels of these compounds into PC. 
4.2 Incorporation of CLnA from pomegranate seed oil into phospholipid (PC)  
 
Pomegranate seed oil contained 75.4% of conjugated linolenic acid as punicic 
acid (C18:3, 9cis, 11trans, 13cis) which makes it a natural source of CLnA.  The 
incorporation of punicic acid into PC was monitored for 96 h.  After 72 h, 11.3% CLnA 
was incorporated and decreased to 8.8% after 96 h. Fatty acid composition of 
pomegranate seed oil, PC and structured phospholipids are shown in Table 9. Punicic 
acid was incorporated into PC mainly by the exchange of linoleic, linolenic and palmitic 
acids. Other fatty acids incorporated randomly with time. Fig. 6 shows the hydrolysis 
ratio of the acidolysis and esterification reaction for the CLnA from ICM from flaxseed 
oil and pomegranate seed oil. The hydrolysis rate was fast during the first 24 h, was 
almost constant at 15% between 24 h and 48 h and reached 20 % after 96 h. Higher  
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Table 8. Fatty acid composition of structured phospholipids 
 (phospholipid + isomerized concentrated mixture from flaxseed oil) at different reaction times 
 
 
Fatty acid composition [% area]† 
 
Substrate Modified Phospholipid 
Fatty acid Phospholipi
d 
ICM 
  
24 h 48 h 72 h 96 h 
C16:0 14.1 ± 0.20 0.1 ± 0.002 10.6 ± 0.01  9.5 ± 0.03  9.0 ± 0.12  9.2 ± 0.04 
C18:0 4.0 ± 0.28 0.2 ± 0.01  3.8 ± 0.07   3.8 ± 0.02   3.6 ± 0.12  3.8 ± 0.06 
C18:1 11.8 ± 1.27 0.5 ± 0.05  10.5 ± 0.14   10.5 ± 0.06  11.2 ± 1.08  10.5 ± 0.16 
C18:2 64.0 ± 0.76 18.4 ± 0.09  60.5 ± 0.12   60.0 ± 0.03  59.1 ± 0.79  59.2 ± 0.13 
C18:3 6.1 ± 0.03 35.6 ± 0.14 10.5 ± 0.06   11.8 ± 0.05  12.3 ± 0.12  12.4 ± 0.07 
CLnA 
isomers  
ND 43.5 ± 0.31 4.0 ± 0.13  4.4 ± 0.03  4.9 ± 0.06  4.8 ± 0.06 
Others ND 1.7 ± 0.01 ND ND ND ND 
†Average of two analyses 
ND – not detected
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hydrolysis rates were reported by Hossen and Hernandez (2005) such as 18.5% and 
19.5% after 72 h for the incorporation of conjugated linoleic acid (CLA) into PC using 
Lipozyme TL IM and Lipozyme RM IM, respectively. 
The fatty acid composition of LPC was determined by GC. Incorporation of linoleic 
acid (C18:2) decreased with reaction time while palmitic acid (C16:0) increased. Fig. 7 
shows the percent of incorporation of CLnA as punicic acid in the LPC. About 17.2% of 
punicic acid was incorporated into LPC after 72 h of reaction, which then decreased to 
9.6% after 96 h. The higher incorporation of punicic acid into the LPC than into the PC 
after 72 h may be explained by the complex reaction kinetics consisting of 
interesterification as well as hydrolysis of PC and by the loss of specificity of the 
enzyme. 
Lypozyme TL IM effectively incorporated two isomers of CLnA, one from 
pomegranate seed oil (punicic acid) and one from ICM from flaxseed oil into PC and 
LPC. This enzyme showed higher incorporation of CLnA as conjugated triene (punicic 
acid) than as conjugated diene from ICM from flaxseed oil. Besides, the high 
concentration of CLnA as punicic acid in the pomegranate seed oil (75.4%) could also 
favor higher incorporation of this isomer into PC. 
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Table 9. Fatty acid composition of structured phospholipid  
(phospholipid+ pomegranate seed oil) at different reaction times 
 
Fatty acid composition [% area]† 
 
Substrate Modified Phospholipid 
Fatty acid Phospholipid Pomegranate 
 seed oil 
24 h 48 h 72 h 96 h 
C16:0 14.1 ± 0.20 3.8 ± 0.09 14.4 ± 0.05 14.4 ± 0.67 10.6 ± 0.11 10.5 ± 0.36 
C18:0 4.0 ± 0.28 2.3 ± 0.21 4.6 ± 0.05 5.1 ± 0.02 4.0 ± 0.06 4.4 ± 0.07 
C18:1 11.8 ± 1.27 6.6 ± 0.12 12.4 ± 0.04 13.2 ± 0.01 11.0 ± 0.04 12.4 ± 0.22 
C18:2 64.0 ± 0.76 11.3 ± 0.28 60.4 ± 0.08 58.3 ± 0.53 57.5 ± 0.06 57.8 ± 1.80 
C18:3 6.1 ± 0.03 0.7 ± 0.01 5.1 ± 0.04 4.7 ± 0.03 4.7 ± 0.04 4.6 ± 0.01 
CLnA   
(Punicic Acid) 
ND 75.4 ± 0.70 3.1 ± 0.18 4.4 ± 0.20 11.3 ± 0.02 8.8 ± 0.32 
†Average of two analyses. 
ND – not detected 
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Figure 8. % Incorporation of CLnA into lysophospholipids (LPC) from isomerized 
concentrated mixture (ICM) and from pomegranate seed oil (PSO) 
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4.3 Physical properties of structured phospholipids produced 
 
Structured phospholipids with CLnA from pomegranate seed oil were produced 
in a larger scale (g amounts) to evaluate two physical properties: dropping point and 
viscosity. The structured phospholipids produced were incorporated in a chocolate 
system, where lecithin is commonly used (unsweetened chocolate 94.6%, coconut oil 
5%, phospholipids 0.4%) for the evaluation of these physical properties.  
4.3.1 Dropping point 
 
The PC-CLnA chocolate system showed lower dropping point (Figure 9) than the 
controls (p<0.05). A chocolate system has a crystalline nature in which physical 
properties such as the dropping point or viscosity could be affected by ingredients like 
fat or phospholipids and their structural characteristics, chain length, unsaturation degree 
and distribution of fatty acids (deMan 2000). The modification of phosphatidylcholine 
through the substitution of palmitic, oleic, or linoleic acid for a three double bond 
conjugated fatty acid (CLnA) could explain this observation as well as the presence of 
lysophospholipids in which one of the fatty acids has been hydrolyzed during the 
enzymatic reaction. 
From a sensory point of view, the differences in the dropping points between the 
structured chocolate system and controls are not significant (< 0.7 °C) as fats can show a 
wide range of melting point which is related with their fatty acid composition. In the 
case of cocoa butter, its melting point goes from 30 to 35 °C.  
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Figure 9. Dropping point PC-CLnA chocolate system and controls (p<0.05) 
  
44 
4.3.2 Viscosity 
 
Lecithin is an important chocolate ingredient as it has been used to decrease 
viscosity and blooming. Viscosity is reduced due to a drop in internal friction and a rise 
in lipophilicity of hydrophilic chocolate ingredients (sugars) which in consequence 
facilitates the formation and stabilization of the emulsion. Furthermore, the reduction of 
viscosity depends on lecithin content and chocolate formulation (van Nieuwenhuyzen 
1995; Nebesny and Żyżelewicz 2005). From the manufacturer point of view, the 
viscosity strongly affects costs and efficiency of chocolate making process (Nebesny and 
Żyżelewicz 2005). 
 The chocolate system used for this study didn’t contain sugar however, the PC-
CLnA chocolate system showed lower viscosities than the controls at 40 and 50 °C 
(p<0.05) (Figure 10). The dropping of viscosity of the PC-CLnA chocolate system at 50 
°C was higher than the one obtained at 40 °C when compared with the controls. The 
modification of the phospholipid through the incorporation of a conjugated fatty acid 
and the presence of lysophospholipids (better emulsifier properties) produced during the 
interesterification reaction could explain these observations.  
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Figure 10. Viscosities of PC-CLnA chocolate system 
 and controls at 40 and 50 °C (p<0.05) 
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4.4 Emulsion stability 
 
Emulsion stability is a kinetic concept. An emulsion is stable when it doesn’t 
have a distinguishable change in the size distribution of the droplets, in their state of 
aggregation, or in their spatial arrangement within the sample vessel, over the time-scale 
of observation (Dickinson and Stainsby 1982). Emulsion stability was evaluated by 
monitoring phase separation by visual observation during storage time. PC-CLnA 
emulsion showed higher emulsion stability than the controls. This emulsion was stable 
up to 108 h while the emulsions without phospholipid and with Lipoid S100 were 48 h 
and 96 h stable, respectively. This observation could be explained due to the presence of 
lysophospholipids in the PC-CLnA emulsion which have better emulsifier properties 
than the phospholipids (Schneider 1997).  
 
4.5 Oxidative stability 
 
Oxidative stability is an important parameter for the quality assessment of animal 
and vegetable fats and oils and lipid-containing foods (Läubli and Bruttel 1986). PC-
CLnA emulsions showed lower oxidative stability, higher peroxide values and p-
anisidine values (Figures 11 and 12) than controls after 1, 3 and 5 days of incubation at 
50 °C. Antioxidant activity has been reported to phospholipids when added to vegetable 
and fish oils (List and Friedrich 1989; King and others 1992). However, because of the 
phosphorous group and polyunsaturated fatty acids that they contain, their role as pro- or 
antioxidant is complex (King and others 1992). The incorporation of a three double bond 
fatty acid (more susceptible to oxidation) into the phospholipid could explain the lower 
oxidative stability of the PC-CLnA emulsions than controls. These results contrast with 
the ones obtained by Hossen (2005). This author observed lower peroxide values and p-
anisidine values (high oxidative stability) of the emulsions prepared with structured 
phospholipids with conjugated linoleic acid at the same conditions and formulation used 
in this study.  
Oxidation during the production of structured phospholipids with CLnA could 
also occur due to reaction temperature, air oxidation, and purification steps. The 
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incorporation of an antioxidant such as tocopherol during the synthesis of the structured 
phospholipids should be considered as this antioxidant has shown to be effective to 
prevent lipid oxidation of conjugated fatty acids (Tsuzuki and others 2004c) and has also 
shown an antioxidant synergistic effect with phospholipids (Ohshima and others 1993). 
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Figure 11. Oxidative stability (peroxide value) of PC-CLnA emulsions 
 and controls (p<0.05) 
  
48 
 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
DAY 1 DAY 3 DAY 7
p
-
A
n
isi
di
n
e 
v
a
lu
e
Control
PC
PC-CLnA
 
Figure 12. Oxidative stability(p-anisidine value) of PC-CLnA emulsions 
and controls (p<0.05) 
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CHAPTER V 
CONCLUSIONS 
 
Conjugated linolenic acids from pomegranate seed oil and an isomerized 
concentrated mixture from flaxseed oil were successfully incorporated into 
phospholipids by an enzymatic reaction. Higher incorporation of conjugated linolenic 
acids from pomegranate seed oil into phospholipids were obtained than for isomerized 
concentrated mixture from flaxseed oil. Higher percents of incorporation of conjugated 
linolenic acids into lysophospholipids were obtained than into phospholipids for both 
sources of these fatty acids. The maximum incorporation of CLnA was 17.2% into 
lysophospholipid after 72 h when pomegranate seed oil was used as a source of the 
conjugated fatty acids. Higher hydrolysis ratio was obtained (around 20% after 96 h) for 
the acidolysis reaction with the isomerized concentrated mixture from flaxseed than 
when the pomegranate seed oil was used. 
Physical properties such as dropping point and viscosity of the structured 
phospholipids produced from pomegranate seed oil were studied. Structured 
phospholipids with CLnA incorporated in a chocolate system showed lower dropping 
point and viscosities (at 40 and 50 °C) than the controls. Emulsion stability of the 
structured phospholipids produced was higher than the controls when they were 
incorporated in whey protein based oil-in-water emulsion after 1, 3, and 7 days at 50 °C. 
Oxidative stabilities of the PC-CLnA emulsions were lower than the controls (higher 
peroxide values and p-anisidine values than controls). 
 Phospholipids are involved in vital biological functions and show interesting 
health benefits and technological properties. Furthermore, they are naturally found in 
living organisms and can be obtained in bulk from natural sources. These characteristics 
make products synthesized from them such as structured phospholipids advantageous 
compounds for the development of nutraceuticals and functional foods.  
  
50 
However, to validate structured phospholipids with CLnA as potential 
nutraceuticals and functional foods further research is needed. The testing of 
bioactivities such as anticancer, hypolipidemic, hypoglycemic, etc, of these structured 
phospholids as well as the study of other physical properties and sensory evaluation of 
food systems in which these compounds have been incorporated are required.  
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